PDCD1 and neoplasm: We further examined the differential contributions of PD-1 and PD-L1 blockade using B16-F10 tumor cells implanted in Pdcd1−/− mice (PD-1 knockoout [KO], Figure 7E), in which PD-1 receptor expression was genetically abrogated within the immune cells of the host.